ADX Antibody (Rabbit mAb) [F18K2]

Application: Reactivity: Mouse, Rat, Human

Usage Information

Dilution
WB1:1000 - 1:10000 IF1:100

Application
WB, IF

Reactivity
Mouse, Rat, Human

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
19 kDa

Datasheet & SDS

Biological Description

Specificity
ADX Antibody (Rabbit mAb) [F18K2] detects endogenous levels of total ADX protein.

Clone
F18K2

Synonym(s)
ADX, FDX1, Adrenal ferredoxin, Ferredoxin-1, Hepatoredoxin

Background
ADX, also known as human mitochondrial ferredoxin 1 (FDX1) or adrenodoxin, is a small [2Fe–2S] iron–sulfur electron carrier that operates in the inner mitochondrial compartment as the central redox shuttle in steroidogenic and other mitochondrial cytochrome P450 systems. The protein comprises an N‑terminal transit peptide for mitochondrial import and a compact ferredoxin fold built around the [2Fe–2S] cluster, with conserved acidic and negatively charged residues along helix 3 and surface domains that mediate electrostatic docking to partner oxidoreductases and P450 enzymes. In the classical adrenal electron transport chain, NADPH donates electrons to FAD-containing adrenodoxin reductase (ADXR), which sequentially reduces ADX one electron at a time; ADX then transfers these electrons to CYP11A1 (P450scc) and other mitochondrial P450s, enabling cholesterol side-chain cleavage to pregnenolone and supporting biosynthesis of glucocorticoids, mineralocorticoids, and sex steroids. ADX is essential for the function of all seven human mitochondrial P450 enzymes (CYP11A1, CYP11B1, CYP11B2, CYP24A1, CYP27A1, CYP27B1 and CYP27C1), and NMR and binding studies show that ADX uses conserved negatively charged residues on its surface to form specific complexes with each P450, with dissociation constants in the low micromolar to nanomolar range that tune electron transfer efficiency for distinct steroid and vitamin A/D metabolic reactions. Mutational analysis of key acidic residues such as Asp76, Arg106 and Asp109 alters binding and redox behavior toward CYP11A1 and other P450s: for example, substitution of Asp76 markedly reduces reductive efficiency toward microsomal CYP2B4, while R106D abolishes complex formation with P450scc but D109R strengthens binding, illustrating how ADX surface charge distribution specifies productive versus nonproductive electron-donor interactions. ADX also supports mitochondrial P450 27C1 and other side-chain oxidation reactions in retinoid and bile acid metabolism, and can function as an alternative electron donor for certain microsomal steroidogenic P450s such as CYP17 and CYP21 when NADPH–P450 reductase is limiting, highlighting its versatility as a redox partner. Physiologically, ADX expression is tightly coupled to steroidogenic demand: in human granulosa cells, cAMP signaling via forskolin and 8‑Br‑cAMP strongly induces ADX mRNA and protein together with steroidogenic factor‑1 and StAR, and immunocytochemistry reveals redistribution and concentration of ADX in clustered mitochondria during progesterone production, placing ADX as a regulated component of the cholesterol side-chain cleavage complex. Genetic and functional studies show that mitochondrial ADXR–ADX–P450 electron transport chains are essential for developmental control of embryogenesis and for endocrine homeostasis, and defects in ADX or its partners impair steroid hormone synthesis and contribute to adrenal insufficiency–like phenotypes.

Background

ADX, also known as human mitochondrial ferredoxin 1 (FDX1) or adrenodoxin, is a small [2Fe–2S] iron–sulfur electron carrier that operates in the inner mitochondrial compartment as the central redox shuttle in steroidogenic and other mitochondrial cytochrome P450 systems. The protein comprises an N‑terminal transit peptide for mitochondrial import and a compact ferredoxin fold built around the [2Fe–2S] cluster, with conserved acidic and negatively charged residues along helix 3 and surface domains that mediate electrostatic docking to partner oxidoreductases and P450 enzymes. In the classical adrenal electron transport chain, NADPH donates electrons to FAD-containing adrenodoxin reductase (ADXR), which sequentially reduces ADX one electron at a time; ADX then transfers these electrons to CYP11A1 (P450scc) and other mitochondrial P450s, enabling cholesterol side-chain cleavage to pregnenolone and supporting biosynthesis of glucocorticoids, mineralocorticoids, and sex steroids. ADX is essential for the function of all seven human mitochondrial P450 enzymes (CYP11A1, CYP11B1, CYP11B2, CYP24A1, CYP27A1, CYP27B1 and CYP27C1), and NMR and binding studies show that ADX uses conserved negatively charged residues on its surface to form specific complexes with each P450, with dissociation constants in the low micromolar to nanomolar range that tune electron transfer efficiency for distinct steroid and vitamin A/D metabolic reactions. Mutational analysis of key acidic residues such as Asp76, Arg106 and Asp109 alters binding and redox behavior toward CYP11A1 and other P450s: for example, substitution of Asp76 markedly reduces reductive efficiency toward microsomal CYP2B4, while R106D abolishes complex formation with P450scc but D109R strengthens binding, illustrating how ADX surface charge distribution specifies productive versus nonproductive electron-donor interactions. ADX also supports mitochondrial P450 27C1 and other side-chain oxidation reactions in retinoid and bile acid metabolism, and can function as an alternative electron donor for certain microsomal steroidogenic P450s such as CYP17 and CYP21 when NADPH–P450 reductase is limiting, highlighting its versatility as a redox partner. Physiologically, ADX expression is tightly coupled to steroidogenic demand: in human granulosa cells, cAMP signaling via forskolin and 8‑Br‑cAMP strongly induces ADX mRNA and protein together with steroidogenic factor‑1 and StAR, and immunocytochemistry reveals redistribution and concentration of ADX in clustered mitochondria during progesterone production, placing ADX as a regulated component of the cholesterol side-chain cleavage complex. Genetic and functional studies show that mitochondrial ADXR–ADX–P450 electron transport chains are essential for developmental control of embryogenesis and for endocrine homeostasis, and defects in ADX or its partners impair steroid hormone synthesis and contribute to adrenal insufficiency–like phenotypes.

References
https://pubmed.ncbi.nlm.nih.gov/32980349/ https://pubmed.ncbi.nlm.nih.gov/20547883/

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%